Colorectal cancer treatment outcomes during the pandemic: Our experience of COVID‐19 at a tertiary referral center
Asia-Pacific Journal of Clinical Oncology · 2024
DOI: 10.1111/ajco.14051 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asia-Pacific Journal of Clinical Oncology, 2024. Verfasst von Christy Kei und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, Western Health, Melbourne, Australia. Hauptthemen laut MEDLINE: COVID-19, Tertiary Care Centers, Colorectal Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Backgrounds The coronavirus disease 2019 (COVID‐19) has led to major shifts in the management of colorectal cancer (CRC). This study aims to identify the impact and early outcomes of COVID‐19 following CRC management at a tertiary referral center in Victoria, Australia.
Methods
This was a retrospective study, utilizing the Australian Comprehensive Cancer Outcomes and Research Database and inpatient records. Patients presenting for CRC management at our institution were identified coinciding with the first Victorian outbreak of COVID‐19 (March 26 to September 26, 2020) (COVID). Management decisions including chemoradiotherapy utilization and surgical outcomes were analyzed within 6 months and compared with the corresponding period in 2019 (pre‐COVID).
Results
A total of 276 patients were included in this study (147 pre‐COVID period, 129 COVID period). During the COVID period, more patients (47.6% vs. 60.5%; p = 0.033) presented symptomatically and less for surveillance (10.9% vs. 2.3%; p < 0.01). Eighty‐four pre‐COVID and 69 COVID period patients proceeded to surgery. The average time from diagnosis date to surgery was 15.6 days less during the COVID period. There were no significant differences in postoperative utilization of higher care ( p = 0.74), complications ( p = 0.93), median hospital length of stay ( p = 0.67), 30‐day readmission ( p = 0.50), or 30‐day reoperation ( p = 0.74). In 1.6% of cases, pandemic impacts resulted in a change in management.
Conclusion
Presentation of patients with CRC varied, with a significant increase in symptomatic presentations and decreased numbers for surveillance. Through flexibility and change in practice, our institution helped improve access to surgical intervention and oncological therapies. Further prospective work is required to identify long‐term outcomes and characterize the effects of ongoing disruptions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Colorectal Surgery, Western Health, Melbourne, Australia.
- Department of Surgery, Western Precinct, The University of Melbourne, Melbourne, Australia.
- Chronic Disease Alliance, Western Health, Melbourne, Australia.
ORCID-Profile: Christy Kei, Richard Gartrell
Zitieren
APA
Kei, C., Gartrell, R., Arafat, Y., Degabriele, E., Yeung, J., Chan, S., Faragher, I., & Yeung, J. M. C. (2024). Colorectal cancer treatment outcomes during the pandemic: Our experience of COVID‐19 at a tertiary referral center. Asia-Pacific Journal of Clinical Oncology. https://doi.org/10.1111/ajco.14051
Vancouver
Kei C, Gartrell R, Arafat Y, Degabriele E, Yeung J, Chan S, et al. Colorectal cancer treatment outcomes during the pandemic: Our experience of COVID‐19 at a tertiary referral center. Asia-Pacific Journal of Clinical Oncology. 2024. doi:10.1111/ajco.14051
BibTeX
@article{Kei2024,
author = {Kei, Christy and Gartrell, Richard and Arafat, Yasser and Degabriele, Elizabeth and Yeung, Josephine and Chan, Steven and Faragher, Ian and Yeung, Justin M C},
title = {Colorectal cancer treatment outcomes during the pandemic: Our experience of COVID‐19 at a tertiary referral center},
journal = {Asia-Pacific Journal of Clinical Oncology},
year = {2024},
doi = {10.1111/ajco.14051}
}
EUVIMED